Pharmaniaga inks local manufacturing deal with Sinovac Biotech


A health worker shows a vial of Sinovac Biotech’s Coronavac during the vaccination of Philippine military at the national headquarters of the Philippine Army in Fort Bonifacio, Taguig City, Metro Manila, Philippines, on Tuesday (March 2, 2021). - Reuters

KUALA LUMPUR: Pharmaniaga Bhd has signed a local manufacturing agreement with China's Sinovac Biotech Ltd's subsidiary for the purchase of ready-to-fill bulk product of Covid-19 vaccine.

The company said on Monday its unit Pharmaniaga Lifescience Sdn Bhd (PLS) and Sinovac Life Sciences Co. Ltd had entered into the agreement on March 12 for the manufacturing of the vaccine by PLS.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Trading ideas: Axiata, Mega First, Vstecs, Pharmaniaga, Sarawak Cable, Paragon Globe, CIMB, IHH, Ni Hsin
Thai business group cuts 2024 GDP growth forecast
TotalEnergies mulls moving listing to Wall St
Rig dearth aggravates Indonesia’s declining oil and gas production
Optimistic growth prospects for Focus Point Holdings
Epsom sees more student enrolment from UK
SC: Planners should give sound financial advice
China’s surging industrial loans aren’t going to its factories
Japan’s helping hand in BoE June rate cut window
Carsome turns Ebitda positive in 1Q24 on business scale

Others Also Read